+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioresorbable Implants Market by Material Type, Application, Product Type, End User - Global Forecast to 2030- Product Image
Bioresorbable Implants Market by Material Type, Application, Product Type, End User - Global Forecast to 2030- Product Image
Sale

Bioresorbable Implants Market by Material Type, Application, Product Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010900
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioresorbable Implants Market grew from USD 5.68 billion in 2024 to USD 6.09 billion in 2025. It is expected to continue growing at a CAGR of 7.23%, reaching USD 8.63 billion by 2030.

Setting the Stage for Bioresorbable Innovations

The landscape of bioresorbable implants is undergoing a profound transformation driven by advancements in material engineering and clinical applications. As the global healthcare sector seeks minimally invasive solutions that reduce the need for secondary surgeries, bioresorbable technologies have emerged at the forefront of innovation. This executive summary delves into the fundamental forces shaping the market, offering a clear view of the factors that will define the next generation of implantable devices.

From the emergence of novel polymer blends to evolving regulatory frameworks, the context for bioresorbable implants is rich with opportunity. Stakeholders ranging from medical device manufacturers to healthcare providers are rethinking traditional paradigms, recognizing that materials designed to gradually degrade in the body can significantly improve patient outcomes. This introduction sets the stage for an in-depth exploration of the currents propelling this segment toward accelerated growth and heightened clinical acceptance.

Paradigm-Shifting Trends Reshaping the Industry

The current era is marked by paradigm-shifting trends reshaping the industry at an unprecedented pace. Technological breakthroughs in polymer synthesis have led to materials with tunable degradation rates and enhanced mechanical properties, enabling tailored solutions for a wider array of clinical indications. Concurrently, advances in additive manufacturing techniques are facilitating the production of patient-specific scaffolds and fixation devices, further expanding the scope of minimally invasive procedures.

Additionally, interdisciplinary collaborations between material scientists, surgeons, and regulatory experts are refining product design and accelerating time to market. This convergence of expertise has fostered an environment where preclinical models are more predictive of clinical performance, reducing development timelines and lowering overall costs. As these transformative shifts take root, the industry is witnessing a shift from generic to precision-engineered implants that better align with individual patient anatomies and healing trajectories.

Tariff Reforms and Their Ripple Effects in 2025

In 2025, newly implemented United States tariffs have introduced a complex set of challenges and opportunities for stakeholders in the bioresorbable implants market. While the additional levies on polymer imports have increased input costs for manufacturers reliant on overseas supply chains, they have simultaneously catalyzed domestic investment in advanced polymer production facilities. This dynamic is fostering a more resilient local supply base while incentivizing material innovation aimed at reducing dependency on imported feedstocks.

At the same time, these tariff adjustments are prompting strategic realignments across the value chain. Device developers are negotiating long-term contracts to hedge against cost volatility, while distributors are reassessing logistical networks to optimize cross-border flows. In parallel, market participants are leveraging the tariff environment to differentiate offerings through value-added services such as technical support for material selection and regulatory navigation. Ultimately, the tariff reforms of 2025 are not merely a cost consideration but a strategic impetus that is reshaping investment priorities and supply chain configurations.

Unveiling Market Segmentation Dynamics

A nuanced understanding of market segmentation lays the foundation for targeted growth strategies. When examining the landscape based on material type, attention turns to polycaprolactone, polyglycolic acid, polylactic acid and polylactic-co-glycolic acid. Each polymer class offers distinct degradation timelines and mechanical profiles, enabling diversified product portfolios from rapid-resorbable repair patches to longer-lasting structural scaffolds. This material heterogeneity underpins the customization of implants across a spectrum of clinical needs.

From the application perspective, cardiovascular implementations are dissected into repair patches, stents and vascular grafts, with further granularity distinguishing vascular scaffolds, coronary grafts and peripheral grafts. Dental procedures leverage bone grafts and membranes to enhance osseointegration, while ophthalmic interventions rely on drug delivery platforms, scaffolds and sutures to address complex ocular conditions. Orthopedic solutions span bone regeneration techniques including grafts, putty and scaffolds, fracture fixation devices such as pins, plates and screws, as well as spine fusion elements like cages, rods and screws.

Evaluating the market through the lens of product type reveals critical insights across drug delivery systems, fixation devices, scaffolds and sutures. Hydrogels and microspheres are redefining controlled-release profiles within drug delivery, whereas fixation devices encompass a spectrum of pins, plates and screws tailored for diverse load-bearing requirements. Bone and tissue scaffolds are enabling regenerative strategies that promote endogenous healing, while braided and monofilament sutures continue to evolve with enhanced tensile strength and biocompatibility.

Finally, end users comprise ambulatory surgical centers, clinics and hospitals, each presenting unique adoption patterns. Surgical centers prioritize rapid turnover and minimally invasive interventions, while clinics focus on cost-effective outpatient procedures. Hospitals, with their access to comprehensive operating suites and clinical trial programs, remain pivotal in pioneering new implant technologies and assembling the real-world evidence needed for broader market penetration.

Regional Market Nuances Driving Growth

Divergence in regional market performance reflects a tapestry of healthcare infrastructures, regulatory pathways and patient demographics. In the Americas, robust reimbursement frameworks and cutting-edge clinical trials are accelerating adoption of bioresorbable technologies. Healthcare providers in North America are integrating these implants into both elective and emergency procedures, supported by an ecosystem that values post-market surveillance and real-world data collection.

Across Europe, Middle East and Africa, variance in regulatory alignment is giving rise to distinct sub-markets. Western Europe’s centralized approval processes and established surgical networks facilitate smoother product launches, whereas regions in the Middle East and Africa often require bespoke market entry strategies to accommodate local regulatory requirements and procurement practices. Despite these complexities, a growing emphasis on cost containment and minimally invasive care is spurring investment in bioresorbable applications.

The Asia-Pacific region is emerging as a pivotal growth engine, driven by expanding healthcare access in populous nations and increasing outlays on medical infrastructure. China’s rapidly expanding regulatory reform initiatives have streamlined pathways for innovative devices, while Japan and South Korea emphasize partnerships between government, academia and industry to fast-track clinical validation. In parallel, Southeast Asian and Oceania markets are cultivating niche opportunities in dental and ophthalmic applications, leveraging regional centers of excellence to pilot novel implant solutions.

Competitive Landscape and Leading Players

The competitive landscape is characterized by a mix of established medical device corporations and agile specialized firms, each vying to define the next wave of bioresorbable offerings. Major players are investing heavily in mergers and acquisitions to acquire innovative polymer platforms and expand their product pipelines. Concurrently, smaller innovators are securing strategic partnerships to leverage distribution networks and regulatory expertise, enhancing their ability to scale from proof-of-concept to global commercialization.

Notable achievements include the development of next-generation copolymers that combine high initial mechanical strength with uniform degradation profiles. Some enterprises are also pioneering integrated ecosystems that couple implantable devices with digital monitoring tools, enabling real-time tracking of degradation kinetics and patient recovery metrics. Success in this arena hinges on navigating complex regulatory landscapes and demonstrating clinical superiority over established non-resorbable alternatives.

Moreover, collaborative consortia involving academic institutions and clinical research organizations are playing a critical role in generating the robust preclinical and clinical data required for market approval. The interplay between technology licensors, contract manufacturers and commercialization partners is fostering a more dynamic innovation cycle. Forward-thinking companies are leveraging these synergies to accelerate development timelines and amplify the impact of their pipeline assets.

Strategic Imperatives for Market Leadership

Industry leaders must adopt strategic imperatives that harness the full potential of bioresorbable technologies. First, securing reliable sources of advanced polymers through long-term partnerships or in-house synthesis capabilities will mitigate exposure to tariff volatility and supply chain disruptions. Simultaneously, integrating material science expertise with clinical insights will enable the design of implants that address unmet therapeutic needs while differentiating offerings in a crowded marketplace.

Second, investing in digital health adjuncts such as sensor-embedded scaffolds and patient monitoring platforms can unlock new value propositions by demonstrating superior postoperative outcomes and cost savings. Such hybrid solutions can also facilitate reimbursement negotiations by generating real-world evidence that underscores clinical and economic benefits.

Finally, expanding into emerging markets requires tailored go-to-market models that respect local regulatory frameworks and procurement norms. Collaborations with regional distributors and contract research organizations can accelerate market access, while targeted education programs for surgeons and healthcare payers will drive adoption. By aligning strategic priorities across supply chain resilience, clinical differentiation and market expansion, industry leaders can position themselves at the vanguard of bioresorbable implant innovation.

Robust Analytical Framework and Data Sources

The insights presented in this report are grounded in a comprehensive analytical framework that combines primary and secondary research. Primary inputs were gathered through in-depth interviews with industry executives, clinicians and regulatory experts, providing nuanced perspectives on material innovations, clinical adoption patterns and policy developments. Secondary sources included peer-reviewed journals, patent filings, company disclosures and government publications, ensuring a robust foundation of empirical evidence.

Quantitative data points were validated through cross-referencing multiple proprietary and publicly available databases, while qualitative findings were triangulated to mitigate bias. The research process encompassed a rigorous assessment of regulatory filings, clinical trial registries and real-world evidence platforms to capture evolving safety and efficacy trends. This triangulated approach underpins the report’s credibility and ensures that strategic recommendations are supported by reliable, up-to-date information.

Synthesis and Future Outlook

As the bioresorbable implants market continues to mature, the convergence of material innovation, regulatory evolution and clinical demand will define its trajectory. Stakeholders equipped with a clear understanding of segmentation dynamics, regional nuances and competitive strategies will be best positioned to capitalize on emerging opportunities. By synthesizing the insights shared across this executive summary, decision-makers can craft informed strategies that accelerate time to market, optimize resource allocation and enhance patient outcomes.

Looking ahead, ongoing collaboration among material scientists, clinicians and policy makers will be essential to overcoming remaining barriers, such as demonstrating long-term safety and securing favorable reimbursement pathways. The collective effort to refine regulatory processes and standardize post-market surveillance will further bolster confidence in bioresorbable solutions. Ultimately, the journey toward widespread clinical adoption will depend on the industry’s ability to innovate responsibly, validate performance rigorously and respond dynamically to shifting healthcare landscapes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Material Type
    • Polycaprolactone
    • Polyglycolic Acid
    • Polylactic Acid
    • Polylactic-Co-Glycolic Acid
  • Application
    • Cardiovascular
      • Repair Patches
      • Stents
        • Vascular Scaffold
      • Vascular Grafts
        • Coronary Grafts
        • Peripheral Grafts
    • Dental
      • Bone Grafts
      • Membranes
    • Ophthalmic
      • Drug Delivery
      • Scaffolds
      • Sutures
    • Orthopedic
      • Bone Regeneration
        • Grafts
        • Putty
        • Scaffolds
      • Fracture Fixation
        • Pins
        • Plates
        • Screws
      • Spine Fusion
        • Cages
        • Rods
        • Screws
  • Product Type
    • Drug Delivery Systems
      • Hydrogels
      • Microspheres
    • Fixation Devices
      • Pins
      • Plates
      • Screws
    • Scaffolds
      • Bone Scaffolds
      • Tissue Scaffolds
    • Sutures
      • Braided
      • Monofilament
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings, Inc.
  • Teleflex Incorporated
  • ConMed Corporation
  • Orthofix Medical Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioresorbable Implants Market, by Material Type
8.1. Introduction
8.2. Polycaprolactone
8.3. Polyglycolic Acid
8.4. Polylactic Acid
8.5. Polylactic-Co-Glycolic Acid
9. Bioresorbable Implants Market, by Application
9.1. Introduction
9.2. Cardiovascular
9.2.1. Repair Patches
9.2.2. Stents
9.2.2.1. Vascular Scaffold
9.2.3. Vascular Grafts
9.2.3.1. Coronary Grafts
9.2.3.2. Peripheral Grafts
9.3. Dental
9.3.1. Bone Grafts
9.3.2. Membranes
9.4. Ophthalmic
9.4.1. Drug Delivery
9.4.2. Scaffolds
9.4.3. Sutures
9.5. Orthopedic
9.5.1. Bone Regeneration
9.5.1.1. Grafts
9.5.1.2. Putty
9.5.1.3. Scaffolds
9.5.2. Fracture Fixation
9.5.2.1. Pins
9.5.2.2. Plates
9.5.2.3. Screws
9.5.3. Spine Fusion
9.5.3.1. Cages
9.5.3.2. Rods
9.5.3.3. Screws
10. Bioresorbable Implants Market, by Product Type
10.1. Introduction
10.2. Drug Delivery Systems
10.2.1. Hydrogels
10.2.2. Microspheres
10.3. Fixation Devices
10.3.1. Pins
10.3.2. Plates
10.3.3. Screws
10.4. Scaffolds
10.4.1. Bone Scaffolds
10.4.2. Tissue Scaffolds
10.5. Sutures
10.5.1. Braided
10.5.2. Monofilament
11. Bioresorbable Implants Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
12. Americas Bioresorbable Implants Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bioresorbable Implants Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bioresorbable Implants Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Medtronic plc
15.3.3. Boston Scientific Corporation
15.3.4. Abbott Laboratories
15.3.5. Stryker Corporation
15.3.6. B. Braun Melsungen AG
15.3.7. Zimmer Biomet Holdings, Inc.
15.3.8. Teleflex Incorporated
15.3.9. ConMed Corporation
15.3.10. Orthofix Medical Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIORESORBABLE IMPLANTS MARKET MULTI-CURRENCY
FIGURE 2. BIORESORBABLE IMPLANTS MARKET MULTI-LANGUAGE
FIGURE 3. BIORESORBABLE IMPLANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIORESORBABLE IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIORESORBABLE IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIORESORBABLE IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BIORESORBABLE IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 106. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 107. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 109. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 110. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 111. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 112. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 113. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 114. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 115. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 116. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 117. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 119. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 120. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 121. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 122. CANADA BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 126. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 129. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 130. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 131. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 132. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 133. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 134. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 210. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 212. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 213. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 214. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 215. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 216. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 217. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 218. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 219. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 220. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 222. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 223. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 224. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 225. GERMANY BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 227. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 229. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 230. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 231. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 232. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 233. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 234. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 235. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 236. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 237. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 239. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 240. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 241. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 242. FRANCE BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 261. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 263. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 264. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 265. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 266. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 267. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 268. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 269. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 270. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 271. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 273. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 274. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 275. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 276. ITALY BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 278. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 280. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 281. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 282. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 283. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 284. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 285. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 286. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 287. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 288. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 291. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 292. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 293. SPAIN BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2030 (USD MILLION)
TABLE 320. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2030 (USD MILLION)
TABLE 322. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 324. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 326. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. SOUTH AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. SOUTH AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY STENT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bioresorbable Implants market report include:
  • Johnson & Johnson
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings, Inc.
  • Teleflex Incorporated
  • ConMed Corporation
  • Orthofix Medical Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.63 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Fibromyalgia Treatment - Global Strategic Business Report - Product Image

Fibromyalgia Treatment - Global Strategic Business Report

  • Report
  • 369 Pages
  • Global
From
Bioresorbable Implant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Bioresorbable Implant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
Bioresorbable Polymers Market by Product, Form, Manufacturing Process, Material Type, Application, End-User - Global Forecast to 2030 - Product Image

Bioresorbable Polymers Market by Product, Form, Manufacturing Process, Material Type, Application, End-User - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Bioresorbable Bone-graft Substitute Market by Delivery Form, Surgical Application, End User - Global Forecast to 2030 - Product Image

Bioresorbable Bone-graft Substitute Market by Delivery Form, Surgical Application, End User - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Bioresorbable Medical Material Market Report 2025 - Product Image

Bioresorbable Medical Material Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Resorbable Implant Market

The Resorbable Implant market is a subset of the larger Biomaterials market. It is composed of medical devices that are designed to be absorbed by the body over time. These implants are typically made of biodegradable polymers, such as polylactic acid, and are used in a variety of medical applications, including orthopedic, cardiovascular, and dental. Resorbable implants offer a number of advantages over traditional implants, such as reduced risk of infection and improved patient comfort. Resorbable implants are becoming increasingly popular due to their ability to reduce the need for multiple surgeries and their potential to reduce the risk of long-term complications. As the technology continues to improve, the market is expected to grow. Some of the major companies in the Resorbable Implant market include Stryker, Zimmer Biomet, DePuy Synthes, and Smith & Nephew. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.